Alan Lotvin's Insider Trades & SAST Disclosures
Alan Lotvin's most recent trade in ProKidney Corp - Ordinary Shares - Class A was a trade of 62,558 Director stock option (right to buy) done . Disclosure was reported to the exchange on May 30, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Alan Lotvin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ProKidney Corp - Ordinary ... | Alan M. Lotvin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 62,558 | 62,558 | - | - | Director stock option (right to buy) | |
| ProKidney Corp - Ordinary ... | Alan M. Lotvin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 48,128 | 48,128 | - | - | Director stock option (right to buy) | |
| CVS Health Corp | Alan M. Lotvin | EVP&President-PharmacyServices | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2022 | 70,398 | 70,399 | - | - | Stock Option | |
| CVS Health Corp | Alan M. Lotvin | EVP&President-PharmacyServices | Sale of securities on an exchange or to another person at price $ 98.00 per share. | 03 Aug 2022 | 70,398 | 109,183 (0%) | 0% | 98 | 6,899,004 | Common Stock |
| CVS Health Corp | Alan M. Lotvin | EVP&President-PharmacyServices | Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.34 per share. | 03 Aug 2022 | 70,398 | 179,581 (0%) | 0% | 58.3 | 4,107,019 | Common Stock |
| CVS Health Corp | Alan M. Lotvin | EVP&President-PharmacyServices | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2022 | 50,501 | 20,201 | - | - | Stock Option | |
| CVS Health Corp | Alan M. Lotvin | EVP&President-PharmacyServices | Sale of securities on an exchange or to another person at price $ 98.00 per share. | 03 Aug 2022 | 50,501 | 109,183 (0%) | 0% | 98 | 4,949,098 | Common Stock |
| CVS Health Corp | Alan M. Lotvin | EVP&President-PharmacyServices | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.19 per share. | 03 Aug 2022 | 50,501 | 159,684 (0%) | 0% | 54.2 | 2,736,649 | Common Stock |
| CVS Health Corp | Alan M. Lotvin | EVP&President-PharmacyServices | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2022 | 22,541 | 0 | - | - | Stock Option | |
| CVS Health Corp | Alan M. Lotvin | EVP&President-PharmacyServices | Sale of securities on an exchange or to another person at price $ 104.00 per share. | 03 Aug 2022 | 22,541 | 109,183 (0%) | 0% | 104 | 2,344,264 | Common Stock |
| CVS Health Corp | Alan M. Lotvin | EVP&President-PharmacyServices | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.21 per share. | 03 Aug 2022 | 22,541 | 131,724 (0%) | 0% | 62.2 | 1,402,276 | Common Stock |
| ProKidney Corp - Ordinary ... | Alan M. Lotvin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 1,514,326 | 1,514,326 | - | - | Common Units in ProKidney LP | |
| ProKidney Corp - Ordinary ... | Alan M. Lotvin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 1,514,326 | 1,514,326 | - | - | Class B Ordinary Shares | |
| CVS Health Corp | Alan M. Lotvin | EVP&President-PharmacyServices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 77,962 | 77,962 | - | - | Stock Option | |
| CVS Health Corp | Alan M. Lotvin | EVP&President-PharmacyServices | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.09 per share. | 01 Apr 2022 | 38,129 | 109,183 (0%) | 0% | 101.1 | 3,854,461 | Common Stock |
| CVS Health Corp | Alan M. Lotvin | EVP&President-PharmacyServices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2022 | 85,971 | 147,312 (0%) | 0% | 0 | Common Stock | |
| CVS Health Corp | Alan M. Lotvin | EVP&President-PharmacyServices | Sale of securities on an exchange or to another person at price $ 106.50 per share. | 01 Feb 2022 | 21,386 | 61,341 (0%) | 0% | 106.5 | 2,277,566 | Common Stock |
| CVS Health Corp | Alan M. Lotvin | EVP&President-PharmacyServices | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2022 | 21,386 | 0 | - | - | Stock Option | |
| CVS Health Corp | Alan M. Lotvin | EVP&President-PharmacyServices | Exercise or conversion of derivative security received from the company (such as an option) at price $ 102.26 per share. | 01 Feb 2022 | 21,386 | 82,727 (0%) | 0% | 102.3 | 2,186,932 | Common Stock |
| CVS Health Corp | Alan M. Lotvin | EVP&President-PharmacyServices | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.78 per share. | 27 Dec 2021 | 200 | 5,827 (0%) | 0% | 88.8 | 17,756 | Common Stock (restricted) |
| CVS Health Corp | Alan M. Lotvin | EVP&President-PharmacyServices | Sale of securities on an exchange or to another person at price $ 83.67 per share. | 28 Jun 2021 | 2,781 | 61,047 (0%) | 0% | 83.7 | 232,686 | Common Stock |
| CVS Health Corp | Alan M. Lotvin | EVP&President-PharmacyServices | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.30 per share. | 03 Apr 2021 | 1,705 | 63,828 (0%) | 0% | 74.3 | 126,682 | Common Stock |
| CVS Health Corp | Alan M. Lotvin | EVP&President-PharmacyServices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 120,940 | 120,940 | - | - | Stock Option | |
| CVS Health Corp | Alan M. Lotvin | EVP&President-PharmacyServices | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 95,669 | 104,121 (0%) | 0% | 0 | Common Stock | |
| CVS Health Corp | Alan M. Lotvin | EVP&President-PharmacyServices | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Feb 2021 | 42,431 | 61,690 (0%) | 0% | 0 | Common Stock | |
| CVS Health Corp | Alan M. Lotvin | EVP and President-CVS Caremark | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 08 Jan 2021 | 25,836 | 8,368 (0%) | 0% | 75 | 1,937,700 | Common Stock |
| CVS Health Corp | Alan M. Lotvin | EVP and President-CVS Caremark | Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.29 per share. | 08 Jan 2021 | 15,736 | 34,204 (0%) | 0% | 74.3 | 1,169,027 | Common Stock |
| CVS Health Corp | Alan M. Lotvin | EVP and President-CVS Caremark | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2021 | 15,736 | 0 | - | - | Stock Option | |
| CVS Health Corp | Alan M. Lotvin | EVP and President-CVS Caremark | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.19 per share. | 08 Jan 2021 | 10,100 | 18,468 (0%) | 0% | 54.2 | 547,319 | Common Stock |
| CVS Health Corp | Alan M. Lotvin | EVP and President-CVS Caremark | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2021 | 10,100 | 70,702 | - | - | Stock Option | |
| CVS Health Corp | Alan Lotvin | EVP and President-CVS Caremark | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 13 Nov 2020 | 7,138 | 8,023 (0%) | 0% | 70 | 499,660 | Common Stock |
| CVS Health Corp | Alan Lotvin | EVP and President-CVS Caremark | Purchase of securities on an exchange or from another person at price $ 63.14 per share. | 11 May 2020 | 5,000 | 15,161 (0%) | 0% | 63.1 | 315,675 | Common Stock |
| CVS Health Corp | Alan Lotvin | EVP, Transformation | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2020 | 140,797 | 140,797 | - | - | Stock Option |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges